Scientists Create Digital Twins of Organs to Speed Up Drug Discovery
Scientists Create Digital Twins of Organs to Speed Up Drug Discovery
Scientists are revolutionizing medicine by building digital twins—sophisticated computer simulations of human organs.
Unlike static models, these digital twins act as dynamic, data-driven replicas that evolve as new information is gathered.
By integrating complex data, from molecular structures to full physiological systems, researchers can now conduct "in silico" experiments.
Organizations like the Modelling-Informed Medicine Centre (MiMeC) are leading this charge, working to standardize these models to speed up development.
While hurdles such as high computational demands and the need for strict data regulation remain, the potential is clear: digital twins could drastically reduce the high failure rates of traditional drug development, lower the reliance on animal testing, and eventually pave the way for precision medicine tailored to an individual’s unique biology.
This technology marks a move toward a faster, more predictive, and safer future for global healthcare.
